Figures & data
![](/cms/asset/e0f35588-6f5a-4c9b-a4d2-d8949dcd1cda/djir_a_12190119_uf0001_b.jpg)
Figure 1 Modified schematic diagram illustrates COVID-19 clinical presentation, diagnostic investigations, assessment of disease severity and consideration of care settings accordingly.Citation2,Citation3,Citation21–Citation23
![Figure 1 Modified schematic diagram illustrates COVID-19 clinical presentation, diagnostic investigations, assessment of disease severity and consideration of care settings accordingly.Citation2,Citation3,Citation21–Citation23](/cms/asset/d298f929-ff36-44a8-8627-8a4de154e3e6/djir_a_12190119_f0001_c.jpg)
Figure 2 Modified schematic diagram illustrates the etiopathogenesis and pathophysiology of COVID-19. Data from Wiersinga et al.Citation64
![Figure 2 Modified schematic diagram illustrates the etiopathogenesis and pathophysiology of COVID-19. Data from Wiersinga et al.Citation64](/cms/asset/f2e1d768-c00d-47cd-aad3-0eea2ad47a39/djir_a_12190119_f0002_c.jpg)
Table 1 The Advantages and Drawbacks of the Therapeutic Strategies in COVID-19 Management
Table 2 Shows the Clinical Trials Registered on ClinicalTrials.gov to October 20, 2020, Utilizing Antiviral Therapies for the Treatment of COVID-19
Table 3 Shows the Clinical Trials Registered on ClinicalTrials.gov To October 20, 2020, Utilizing Prospective Therapies for the Treatment of COVID-19
Figure 3 Modified schematic diagram illustrates the cellular and molecular cascade of PBMT that reserve SARS-CoV-2 cellular and molecular activities to prevent ARDS.
Notes: Adapted with permission from Mokmeli S, Vetrici M. Low level laser therapy as a modality to attenuate cytokine storm at multiple levels, enhance recovery, and reduce the use of ventilators in COVID–19. Can J Respir Ther. 2020;56:1–7.Citation200
![Figure 3 Modified schematic diagram illustrates the cellular and molecular cascade of PBMT that reserve SARS-CoV-2 cellular and molecular activities to prevent ARDS.Notes: Adapted with permission from Mokmeli S, Vetrici M. Low level laser therapy as a modality to attenuate cytokine storm at multiple levels, enhance recovery, and reduce the use of ventilators in COVID–19. Can J Respir Ther. 2020;56:1–7.Citation200](/cms/asset/cbf8594c-2a34-4344-bb18-6edaea6ac4f7/djir_a_12190119_f0003_c.jpg)
Table 4 Shows the Clinical Trials Registered on ClinicalTrials.gov To October 20, 2020, Utilizing Phototherapy for the Treatment of COVID-19